donor lymphocyte infusion
MRD-directed DLI-2016
Phase 3 mab completed
Quick answer
donor lymphocyte infusion for Minimal Residual Disease is a Phase 3 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Minimal Residual Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed